DC-SIGN -139 is located close to one of the binding sites of the transcription factor AP-1 in the promoter region of DC-SIGN, and we could speculate that the substitution of one nucleotide close to this site may change the level of expression of DC-SIGN and further contribute to the progression of NPC. Here, CD209 is linked to nasopharyngeal carcinoma.